This Will Be Check For Plagiarism And In APA 6th Edproposal Paper On 1 This will be check for PLAGIARISM and in APA 6TH ED Proposal paper on 1,255 words for a major change project that I would like to lead. (Sickle Cell Disease) Them Identify a health care issue in Sickle Cell Trait and Sickle Cell Carrier and explain why. Develop a rationale using evidence-based research, must including: 1) The background. 2) Statistical findings. 3) Probable stakeholders. 4) Logical conclusions. Design and implementation plan for the project, including: 1) A communications plan. 2) Creation of a design and implementation team by roles. List the strategies you would use to lead the team to success and identify potential obstacles that may be faced, along with plans to deal with them.
Paper For Above instruction Sickle Cell Disease (SCD) remains a significant public health challenge worldwide, particularly affecting populations with higher prevalence among individuals of African, Mediterranean, Middle Eastern, and Indian ancestry (National Heart, Lung, and Blood Institute, 2022). This proposal aims to develop a comprehensive change project that seeks to enhance awareness, early detection, and management of individuals with Sickle Cell Trait (SCT) and Sickle Cell Carrier status. Despite being generally asymptomatic, SCT carriers have health implications and can pass the gene to offspring, making public health education and genetic counseling critical components of disease control. The background of this healthcare issue underscores the genetic nature of SCD and SCT, which results from inheriting the sickle hemoglobin gene (HbS). According to the Centers for Disease Control and Prevention (CDC, 2023), approximately 1 in 13 Black or African American individuals carries the sickle cell trait, with higher prevalence observed in specific geographic regions. The condition can lead to complications under extreme physical stress, dehydration, or high-altitude exposure, and recent studies have suggested that carriers might have increased risks for certain health issues, such as blood in the urine or exertional rhabdomyolysis (Smith et al., 2021). Public awareness about these risks remains limited, contributing to delayed diagnosis and management. Statistically, the burden of SCT in the United States highlights the urgency for targeted interventions. The CDC reports that over 100,000 Americans are affected by SCD, with a significant proportion being carriers—an estimated 3 million individuals (CDC, 2023). The prevalence of sickle cell trait in African Americans is approximately 1 in 13, which underscores the need for culturally tailored education programs. Moreover, early genetic screening programs have demonstrated effectiveness in identifying